Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Chemicals Specialty Chemicals
Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Ceapro Inc > Category breaker
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(107)
•••
Comment by prophetoffactzon Feb 29, 2024 10:29am
56 Views
Post# 35906356

RE:RE:RE:RE:Category breaker

RE:RE:RE:RE:Category breaker
Tencents wrote: Yes offered to potentiel partners who would evaluate the potentiel and if positive plan the approvals and road to market 
but not marketed to end users
thats years away 



No. The 50L facility expected to be commissioned in the next 30 days will provide material for potential partners, formulation and testing. The 100L facility expected to be commissioned in Q3 is a small-scale commercial facility that lets CZO sell product.

In the following video at 23:40 Gilles notes the 50L facility will provide clinical study material and the 100L facility is small-scale commercial and will allow CZO to start marketing yeast beta glucan.

"... this product could be offered as an immune booster before year end 2024." news release




<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities